Ironwood Pharmaceuticals (IRWD) FCF Margin (2010 - 2026)
Ironwood Pharmaceuticals (IRWD) reported FCF Margin of 4.81% for Q1 2026, down 4362.0% on a YoY basis from 0.11% in Q1 2025, and down 96.92% sequentially from 156.31% in Q4 2025.
Ironwood Pharmaceuticals (IRWD) FCF Margin (2010 - 2026) Analysis & Trends
Ironwood Pharmaceuticals (IRWD) has 17 years of FCF Margin data on file, last reported at 4.81% in Q1 2026.
- For the quarter ending Q1 2026, FCF Margin fell 4362.0% year-over-year to 4.81%; the trailing twelve-month figure through Mar 2026 stood at 31.04% (up 636.0% YoY), and the FY2025 full-year result was 42.89%, up 1346.0% from the prior year.
- FCF Margin retreated to 4.81% in Q1 2026, from 156.31% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 156.31% in Q4 2025 to a low of 17.68% in Q2 2025.
- A 5-year average of 46.38% and a median of 38.98% in 2025 frame the typical range for FCF Margin.
- Peak annual rise in FCF Margin reached 13951 bps in 2025, while the deepest fall reached 5307 bps in 2025.
- Tracing IRWD's FCF Margin over 5 years: stood at 73.89% in 2022, then slumped by 59 bps to 30.3% in 2023, then sank by 45 bps to 16.8% in 2024, then jumped by 830 bps to 156.31% in 2025, then sank by 97 bps to 4.81% in 2026.
- Business Quant data shows IRWD's FCF Margin at 4.81% in Q1 2026, 156.31% in Q4 2025, and 38.98% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -5.22% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 12.86% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -5.35% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 46.54% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 9.93% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 17.73% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -2.77% |
| 10 | Ironwood Pharmaceuticals | 619.48 Mn | 399.01 Mn | - | 4.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.81% |
| Dec 31, 2025 | 156.31% |
| Sep 30, 2025 | 38.98% |
| Jun 30, 2025 | -17.68% |
| Mar 31, 2025 | 48.42% |
| Dec 31, 2024 | 16.80% |
| Sep 30, 2024 | 10.77% |
| Jun 30, 2024 | 35.39% |
| Mar 31, 2024 | 59.99% |
| Dec 31, 2023 | 30.30% |
| Sep 30, 2023 | 28.50% |
| Jun 30, 2023 | 32.56% |
| Mar 31, 2023 | 77.03% |
| Dec 31, 2022 | 73.89% |
| Sep 30, 2022 | 63.54% |
| Jun 30, 2022 | 63.02% |
| Mar 31, 2022 | 65.74% |
| Dec 31, 2021 | 55.02% |
| Sep 30, 2021 | 72.35% |
| Jun 30, 2021 | 46.69% |